BGLC

BioNexus Gene Lab Corp.

$0.82

-1.19%
SectorBasic MaterialsIndustrySpecialty ChemicalsCountryMalaysia

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process.

Source: Yahoo Finance
Q-Score37/ 100
Market Cap$2.4M
P/E—
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta-0.09
AI summary

Price & performance

1M-23.2%
3M-27.8%
YTD-69.4%
1Y-76.8%
52-week range—
Beta-0.09
Full chart and returns against a benchmark

Q-Score

37/ 100

Quality against peers; 50 is the peer median.

Growth22
Risk22
Performance68
Valuation41
Profitability32
Leverage56
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$7.4M-21.9%
Net income-$3M
Net margin-40.2%-23.4 pts
Historical fundamentals

Red flags in filings

3active red flags
Going-concern doubtApr 14, 2026
Material weakness in controlsApr 14, 2026
Late filing noticeMar 31, 2026
Filings, findings and the timeline

Revenue exposure

Malaysia79%
MV9%
LK6%
Regions, segments, customers and suppliers

Valuation

BGLCIndustryP/E—35.74P/S0.773.46EV/EBITDA—25.76P/B0.314.79PEG—1.57
Dividend yield0.00%
Every valuation metric